From Hit Compound to Clinical Trials: Seminar on Biotechnology Commercialization
About event
From Hit Compound to Clinical Trials: Seminar on Biotechnology Commercialization
Event Announcement
On May 21 at 10:00 AM, a seminar titled “From Hit Compound to Clinical Trials” will take place at the Latvian Institute of Organic Synthesis (OSI), Aizkraukles street 21, Riga. The event is dedicated to biotechnology commercialization and the path of drug development from laboratory discoveries to clinical trials.
The seminar will be led by Dr. Scott Dax – an internationally recognized expert with more than 25 years of experience in research and development leadership within both large pharmaceutical companies and innovative biotech firms. His professional background covers chemistry, drug discovery, pharmacology, technology, and intellectual property.
Seminar Program:
- 09:50 – Registration
- 10:00 – Introduction
- 10:05 – Lecture by Dr. Dax
- 10:50 – Q&A session
- 11:25 – Networking
Working language: English
The seminar is intended for researchers, students, and anyone interested in drug development and commercialization. Researchers planning to submit projects within the framework of the “BioPhoT – Biomedical and Photonics Research Platform for Innovative Product Development” are especially encouraged to participate.
Registration is required: https://lu.ma/uvhdn7em
______
The event is funded by the Long-Term State Research Programme project “BioPhoT – Biomedical and Photonics Research Platform for Innovative Product Development” (project No. IVPP-EM-Inovācija-2024/1-0002).
Date of event:
May 21, 2025
Time:
10:00 am - 12:10 pm
Target audience:
researchers entrepreneurs
Place of event:
Add to your calendar: